Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction
- PMID: 1519192
- PMCID: PMC1021004
- DOI: 10.1136/thx.47.3.162
Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction
Abstract
Background: Assessing the reversibility of airflow obstruction by peak expiratory (PEF) measurements would be practicable in general practice, but its usefulness has not been investigated.
Methods: PEF measurements were performed (miniWright peak flow meter) in 73 general practice patients (aged 40 to 84) with a history of asthma or chronic obstructive lung disease before and after 400 micrograms inhaled sulbutamol. The change in PEF was compared with the change in forced expiratory volume in one second (FEV1). Reversible airflow obstruction was analysed in two ways according to previous criteria. When defined as a 9% or greater increase in FEV1 expressed as a percentage of predicted values reversibility was observed in 42% of patients. Relative operating characteristic analysis showed that an absolute improvement in PEF of 60 l/min or more gave optimal discrimination between patients with reversible and irreversible airflow obstruction (the sensitivity and specificity of an increase of 60 l/min in detecting a 9% or more increase in FEV1 as a percentage of predicted values were 68% and 93% respectively, with a positive predictive value of 87%). When defined as an increase of 190 ml or more in FEV1, reversible airflow obstruction was observed in 53% of patients. Again an absolute improvement in PEF of 60 l/min or more gave optimal discrimination between patients with reversible and irreversible airflow obstruction (sensitivity 56%, specificity 94%, and positive predictive value 92%).
Conclusion: Absolute changes in PEF can be used as a simple technique to diagnose reversible airflow obstruction in patients from general practice.
Similar articles
-
Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV(1) in primary care patients presenting with a persistent cough?Thorax. 1999 Dec;54(12):1055-60. doi: 10.1136/thx.54.12.1055. Thorax. 1999. PMID: 10567623 Free PMC article.
-
Peak expiratory flow as a screening tool to detect airflow obstruction in a primary health care setting.Int J Tuberc Lung Dis. 2012 May;16(5):674-80. doi: 10.5588/ijtld.11.0429. Epub 2012 Mar 7. Int J Tuberc Lung Dis. 2012. PMID: 22409956
-
Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma.Am J Respir Crit Care Med. 1998 Sep;158(3):827-32. doi: 10.1164/ajrccm.158.3.9707093. Am J Respir Crit Care Med. 1998. PMID: 9731012
-
The diagnostic and screening capacities of peak expiratory flow measurements in the assessment of airway obstruction and bronchodilator response in children with asthma.Monaldi Arch Chest Dis. 2003 Apr-Jun;59(2):155-9. Monaldi Arch Chest Dis. 2003. PMID: 14635506
-
The use of peak expiratory flow rate measurements in respiratory disease.Pediatr Pulmonol. 1991;11(2):166-74. doi: 10.1002/ppul.1950110215. Pediatr Pulmonol. 1991. PMID: 1758735 Review. No abstract available.
Cited by
-
Factors Contributing to 50-ft Walking Speed and Observed Ethnic Differences in Older Community-Dwelling Mexican Americans and European Americans.Phys Ther. 2015 Jun;95(6):871-83. doi: 10.2522/ptj.20140152. Epub 2015 Jan 15. Phys Ther. 2015. PMID: 25592187 Free PMC article.
-
GEMA 5.3. Spanish Guideline on the Management of Asthma.Open Respir Arch. 2023 Sep 19;5(4):100277. doi: 10.1016/j.opresp.2023.100277. eCollection 2023 Oct-Dec. Open Respir Arch. 2023. PMID: 37886027 Free PMC article.
-
Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.Lung India. 2015 Apr;32(Suppl 1):S3-S42. doi: 10.4103/0970-2113.154517. Lung India. 2015. PMID: 25948889 Free PMC article. No abstract available.
-
Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.Br J Gen Pract. 1996 Jan;46(402):15-8. Br J Gen Pract. 1996. PMID: 8745846 Free PMC article. Clinical Trial.
-
Overview of nebuliser treatment.Thorax. 1997 Apr;52 Suppl 2(Suppl 2):S25-30. doi: 10.1136/thx.52.2008.s25. Thorax. 1997. PMID: 9155848 Free PMC article. No abstract available.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical